RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and mitomycin-C for the reduction of acute …

…, K Winter, RJ Myerson, MD Goodyear… - International Journal of …, 2013 - Elsevier
PURPOSE: A multi-institutional phase 2 trial assessed the utility of dose-painted intensity
modulated radiation therapy (DP-IMRT) in reducing grade 2+ combined acute gastrointestinal …

The thrombogenic effect of anticancer drug therapy in women with stage II breast cancer

…, M Gent, J Hirsh, A Arnold, MD Goodyear… - … England Journal of …, 1988 - Mass Medical Soc
Thromboembolic disease has long been recognized as a complication of cancer. Recent
reports have suggested that drugs used in the treatment of cancer, including chemotherapeutic …

The declaration of Helsinki

MDE Goodyear, K Krleza-Jeric, T Lemmens - Bmj, 2007 - bmj.com
The Declaration of Helsinki is a respected institution and one of the most influential documents
in research ethics, 1 w1-w7 having withstood five revisions and two clarifications since its …

[PDF][PDF] Randomized placebo-controlled study of low-dose warfarin for the prevention of central venous catheter–associated thrombosis in patients with cancer

S Couban, M Goodyear, M Burnell, S Dolan… - Journal of Clinical …, 2005 - Citeseer
Purpose In this multicenter, randomized, placebo-controlled clinical trial, we studied whether
warfarin 1 mg daily reduces the incidence of symptomatic central venous catheter (CVC) …

Quality of life in stage II breast cancer: an instrument for clinical trials.

…, M Gent, S De Pauw, MD Goodyear… - Journal of Clinical …, 1988 - ascopubs.org
A questionnaire has been developed for use as an outcome measure in clinical trials of
adjuvant chemotherapy in women with stage II breast cancer. The selection of items for this …

Good outcome associated with a standardized treatment protocol using selective postoperative radiation in patients with clinical stage I adenocarcinoma of the …

…, GJ O'Connell, CR Johanson, MD Goodyear… - Gynecologic …, 1995 - Elsevier
In 1982, a treatment protocol was instituted for the management of patients with clinical stage
I adenocarcinoma of the endometrium. All pertinent historical, operative, and pathologic …

Learning from the TGN1412 trial

M Goodyear - Bmj, 2006 - bmj.com
Michael Goodyear, assistant professor (MGoodyea{at}dal.ca) … Goodyear M. … Articles
by Michael Goodyear

Protection of sex workers

MDE Goodyear, L Cusick - BMJ, 2007 - bmj.com
Michael DE Goodyear, assistant professor (mgoodyear{at}dal.ca)1, … Goodyear M,
Lowman J, Fischer B, Green M. Prostitutes are people too. Lancet 2005;366:1264-5 …

Long-term outcomes of NRG oncology/RTOG 0529: a phase 2 evaluation of dose-painted intensity modulated radiation therapy in combination with 5-fluorouracil and …

…, KA Winter, RJ Myerson, MD Goodyear… - International Journal of …, 2022 - Elsevier
Purpose A multi-institutional phase 2 trial assessed long-term outcomes of dose-painted
intensity modulated radiation therapy (IMRT) with 5-fluorouracil (5FU) and mitomycin-C (MMC) …

Diastereoselective synthesis of the potent antiviral agent (-)-2'-deoxy-3'-thiacytidine and its enantiomer

…, HLA Tse, TS Mansour, MD Goodyear… - The Journal of …, 1995 - ACS Publications
The discovery of the potent anti-human immunodefi-ciency virus (HIV) properties of 3'-azido-3'-deoxythymidine
(AZT) has stimulated intensive efforts in the field of nucleosides …